greater than tq hour,; (morphine -I~ hour,;).
The incidence of nausea and vomiting wa,; low with hoth drugs and piritramide appeared to exert a slight anti-emetic effect.
I KTROlHJCTIO]'{ Piritramide i,; a reccnth' dewlopcd, potent, long-acting narcotic analgesic.
A very low incidence of nausea and vomiting and few serious side effects have been reported following its us('.
It is a diphenylpropylamine d('rivativl', synthesiz ('d b\' .J anssen l'harmaceutica, Belgium, and contains two piperidine ring,;. It i,; structurall~T related to pethidine (Figure 1) . The drug has been extensively' studied in Scandinavia (Janssen 1961, }; 'ilsson 1963, Jorgensen ct al. 1 !H35, Lund et al. 19tiil, Saarne BI(9) , in Continental Europe (Fauvet 196!i, Frank 19tiil, Delooz and Van De Walle 19tiR, \\'('\'ne et al. 196R) and in Britain (Ray 1971) .
It has alsl' been investigated thoroughl\' by the Committee on Drug Addiction and Narcotics in the United Stat ('s (Frazer et al. 1961, 196~, 19ti:3) .
The object of this present study is to compare the potency, duration of action and incidence of nausea and vomiting of piritramide with that of morphine.
l' B.Sc., Statistician, Ethllor Pt)'. Ltd., Sydney. ,\ddrcss for reprints: Dr. David Cihb, St. Vinccnt's Hospital, Darlillg'hurst, X.S."'., ::!OlO.
A double-blind trial was conducted in which piri tramide 15 mg and morphine 10 mg ,,'ere compared. Initiall~' there were lOO identical coded 2 ml ampoules, 50 contailJing piritramide and 50 containing morphine.
These were assigned randomly to consecuti\'e patients in the series. I. -The structural formula of piritramide cOlllparcd with that of pethidine. The chemical name is:!, :! -c1iphenyl-4 -LI -(4 -carbamoyl-4 -piperidino)piperidine J-butyronitrile. I t has also bcen known as pirinitramide, R 3:16;";, "-\RC-T-D-::!l, " Dipidolor " and " Pridolan ".
Patients with severe pain follo\\'ing upper abdominal surgery were used as subjects in this trial. The degree of pain \\ as assessed (a) before, and (b) one hour after an intramuscular injectioll of the analgesic. A ,;coring system was developed to measure the analgesic effect.
The score was estimated from the patient's statements and his appearance, his ability to take a deep breath and to cough, and his ability to move his legs and sit up in bed. These were grouped under the headings" Pain ", " Breathing" and" Movement" and a score of 0-1 was assigned to each (Table 1) . Originally it was hoped that the respiratory effects would be evaluated quantitatively by measuring the tidal volume with a spirometer, but this proved impractical.
The nausea-vomiting inducing, or anti-emetic poteptial, was also observed and scored (Table 1) 19 that this was a clinical trial and wen' left to give a second analgesic Injection (usually morphine or pethidine) when they thought it was necessan'. In only two cases did they fail to record the time of this injection. . The patient's particulars, details of the operation and the scores were all recorded on a chart (Figure 2 ).
RESULTS
The trial was tenninated after fiO cases. Most of the assessments were made bv the author. A few were made by other individuals, who tended to giYe a higher' pain relief score to The three aspects of post-operatiye analgesic obserYation, pain, movement and breathing were analysed separately and in combination (Tables 2, 3, 4 and 5). In no case did the chisquare tests show a significant difference between the two drugs, although the powerful KoImogorov-Smirnov test indicated that morphine was slightly more potent at the doses used . The incidence of nausea and vomiting was low with both drugs and no statistical inferences could be drawn from this aspect of the trial.
On the other hand there was a significant difference at the 5 per cent level between the duration of action of the two drugs (Table 6) , the mean time until the second dose of analgesic was required being 4 hours 43 minutes for morphine and 6 hours 36 minutes for piritramide, There was a wide variation in the duration of action recorded for both morphine (105-555 minutes) and piritramide (50-1,440 minutes) during the trial, and to compensate for this analysis of variance was applied (Table 7) .
Owing to this great variation between individual times, it is preferable to consider the x 2 = 5.626 0.30<: Po( 0.40 more stringent results of the analysis of variance. While the significance level is slightly higher, it is more informative as it pertains purely to the difference between the drugs free from the influence of the variation from one subject to another. Seven per cent is comfortably near enough to the conventional 5 per cent level to suggest that the effects of the two drugs in respect of the time until a second dose of analgesic is required are not identical.
DISCUSSION
The assessment of the pain-relieving properties of potential analgesics has always been difficult.
Initially the drugs are usually tested against a placebo in a double-blind trial, and once their effectiveness is established they are further assessed against a known potent analgesic such as morphine.
In laboratory animals painful stimulation by heat (Eddy Hot Plate Test, Rat Tail-flick Test) or electricity has been used in analgesiometric studies (Eddy et al. ] 950, Sykes and Vickers 1970) .
In clinical trials skin heating, mechanical pressure on subcutaneous bones and electrical stimulation of the tooth pulp have been used to produce pain. While these may allow sharp " end-points" and reproducible results, their relevance to the relief of surgical pain has been questioned. In fact it has been said that muscle ischaemia provides the only form of artificial pain that is relevant in the study of clinical pain relief. Ohviously, the best test of an analgesic IS its ability to relieve pain in the suffering patient. It is in this situation, however, tbat it is most difficult to quantify results and the aim of the present study was to attempt such a quantitative assessment.
The difficulty in establishing the effectiveness of a new analgesic dru!', is highlighted by the rpsults of Dundee and Moore (1960) and Lund et al. (1965) . Both compared morphine with piritramide 15 mg. The former authors, using a subcutaneous pressure method, stated that an equianalgesic dose of morphine was in the range 17-23 mg. The latter, using patients following upper ahdominal surgery, found that the analgesic effectiveness of the drug exceeded that of 5 mg of morphine hut was less than that of ]0 mg.
.·lllaestliesia alld !lltellSi, 'e Care, Fol. T, No. 4, J, ·fay, H17.3 Narcotic analgesics as a group have two serious side-effects. First, they cause depression of the respiratory centre (S,verdlow 1967) which limits the maximum safe dose which can be administered. Second, prolonged use frequently leads to physical dependence and tolerance.
Studies of respiratory depression, using spirometry or PaC0 2 estimations, indicate that approximately equianalgesic doses of morphine and piritramide (10 mg and 15 mg respectively) produce a similar effect (J0rgensen et al. 1965, been used in the treatment of chronic pain, addiction has rarely been reported (Fauvet 1965) . Piritramide does not produce euphoria and is thus unlikely to be sought by addicts for its pleasurable effects.
A very low incidence of nausea and vomiting following the administration of piritramide has been recorded by most authors. This incidence is much less than is seen with other narcotic analgesics (Table 8 ). In the present series nausea and vomiting were rare with both drugs. In five cases, however, where the patient Lund et al. 1965 , Saarne 1969 . As with other narcotic analgesics, the respiratory depressant action of piritramide is reversed by morphine antagonists. However, Saarne found that it was never necessary to administer such antagonists in his series in which 25,206 intramuscular injections of 10-20 mg of piritramide were given. Although piritramide was initially thought to have no addictive properties physical dependence and withdrawal symptoms have now been described and the drug has beep used as a substitute for heroin in withdrawal therapy (Fraser et al. 1961 , 1962 , Snyder 1962 , Fraser 1963 , Frank 1965 ). Saarne, however, did not detect physical dependence or tolerance in his 9,756 patients and, even where the drug has Usually 25,206 15 mg 1.0$ was vomiting before the administration of the analgesic piritramide appeared to produce an anti-emetic effect. This is in agreement with the findings of Saarne (HI69). Another effect of piritramide was the production of mild sedation which has been commented on by other authors (Delooz and Van De Walle 1968, Saarne 1969, Kay 197] ). Rarely, side effects such as vertigo, dizziness and cardiovascular depression have been reported in the literature. These were not seen in the present series.
The duration of action of piritramide recorded in this trial (396 minutes) is in agreement with the results of Saarne (379 minutes) and was considerably longer than morphine (283 minutes). Anaesthesia and Intensive Care, Vol. I, No. 4, llIay, 1973 D Our experience indicates that piritramide is a good post-operative analgesic with 8 long duration of action and produces a comfortable, non-vomiting and sedated (but not confused) patiellt. ACKNOWLEDGEMEKTS We would like to thank Dr. vVarren Walker and Dr. Leon Harris (Ethnor Pty. Ltd.), who designed the protocol for the trial. Dr. Harris also supplied the trial drugs and helped in the final preparations of the paper. "'e are also grateful to Dr. John Griffith and Dr. Walker, who carried out some of the initial assessments. Finally, wc would like to thank Dr. Brian Dwycr for his encouragement and helpful suggestions.
